共 185 条
[1]
Uusitalo E(2015)Incidence and mortality of Neurofibromatosis: a Total population study in Finland J Invest Dermatol 135 904-906
[2]
Leppävirta J(2014)Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease Dev Period Med 18 297-306
[3]
Koffert A(2015)A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor Nat Rev Cancer 15 290-301
[4]
Suominen S(2009)Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression Bone 44 243-250
[5]
Vahtera J(2009)Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options Am J Med Genet A 149A 2327-2338
[6]
Vahlberg T(2014)Neurofibromatosis type 1: a multidisciplinary approach to care Lancet Neurol 13 834-843
[7]
Abramowicz A(2005)Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body Osteoporos Int 16 928-936
[8]
Gos M(2007)Multiple roles for neurofibromin in skeletal development and growth Hum Mol Genet 16 874-886
[9]
Ratner N(2011)Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I Hum Mol Genet 20 3910-3924
[10]
Miller SJ(2014)Neurofibromin inactivation impairs osteocyte development in Nf1Prx1 and Nf1Col1 mouse models Bone 66 155-162